Blood typing has become a routine test item of clinical blood transfusion department and clinical laboratory, which includes ABO blood group, Rh blood group, and cross-matching of blood test.

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

Roche announced on Wednesday that it received CE marking for two of its SARS-CoV-2 tests to run on the firm's new Cobas 5800 system.

On February 21, the Notification on Regulating the Adjustment of Some Medical Service Prices, which included 16 assisted reproductive technologies such as artificial insemination and embryo transfer into Beijing medical insurance, was issued.

Traces of the SARS-CoV-2 coronavirus that causes COVID-19 can be detected in microscopically small fluid droplets exhaled during a very short time span. This is the finding of a new study from the University of Gothenburg.

OraSure Technologies reported after the close of the market Wednesday that its fourth quarter 2021 revenues increased 1 percent year over year.

Agilent Technologies reported after the close of the market on Tuesday that its fiscal first quarter revenues rose 8 percent year over year.

Bio-Techne said on Tuesday that it has inked a development and license agreement with Thermo Fisher Scientific to complete development of and commercialize Bio-Techne's ExoTru kidney transplant rejection test, a multigene urine-based assay.

On February 23, Lepu Biopharma Co., Ltd. was listed on Hong Kong Exchanges and Clearing Limited (HKEX), stock code: 2157.HK. The issue price is HKD 7.13 per share, and public offering raised about HKD 900 million.

Recently, Shenzhen Third People's Hospital/The Second Affiliated Hospital of Southern University of Science and Technology and Roche Diagnostics formally reached a strategic cooperation to jointly establish the "Roche Strategic Cooperation Hospital".

Hypoxia-triggered platinum supernanoparticles dissociated into ultrasmall platinum nanoclusters, which could be cleared by the kidney through urine, in response to the tumor microenvironment.

Illumina and Beckman Coulter Life Sciences said on Tuesday that they have partnered on application development for the Biomek NGenius next-generation library preparation system.